Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) EPS (Basic) (2022 - 2025)

Historic EPS (Basic) for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$4.74.

  • bioAffinity Technologies' EPS (Basic) rose 206.61% to -$4.74 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4, marking a year-over-year increase of 28943.53%. This contributed to the annual value of -$0.75 for FY2024, which is 1807.13% up from last year.
  • As of Q3 2025, bioAffinity Technologies' EPS (Basic) stood at -$4.74, which was up 206.61% from -$0.17 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' EPS (Basic) registered a high of $0.22 during Q4 2022, and its lowest value of -$4.84 during Q3 2024.
  • Its 4-year average for EPS (Basic) is -$0.86, with a median of -$0.2 in 2023.
  • Its EPS (Basic) has fluctuated over the past 5 years, first surged by 7777.78% in 2023, then tumbled by 176153.85% in 2024.
  • bioAffinity Technologies' EPS (Basic) (Quarter) stood at $0.22 in 2022, then tumbled by 218.18% to -$0.26 in 2023, then rose by 5.89% to -$0.24 in 2024, then tumbled by 1837.13% to -$4.74 in 2025.
  • Its EPS (Basic) stands at -$4.74 for Q3 2025, versus -$0.17 for Q2 2025 and -$0.16 for Q1 2025.